Statistically, the world’s population has been rapidly increasing since the advent of the 21st century. As a result of this, the cost of living has increased so much that it has become very difficult for people to survive in third-world countries; one major knock-on effect is the loss of human lives at the hands of curable diseases. The question of whether drug companies should make their products easily available by lowering their prices or not is debatable.
The inaccessibility of quality health services for the common man has been taking human lives. People are dying from curable diseases only because they cannot afford medications and treatments and this cycle will keep on continuing unless the above-mentioned conditions are reversed or any significant measures are taken. Affordable health services for every individual are a basic necessity and play a key role in the growth and development of a nation. If the drug companies make their medications easily accessible by reducing the costs at least to the needy, a lot of lives can be saved and it will also create an overall positive impact. It will give the sick the needed motivation and hope that they will survive. Moreover, timely proper treatments can also stop the spread of contagious curable diseases.
Despite the effective results of accessible medications, it’s still a controversial topic for drug companies as this would affect their overall profits and businesses. This issue can only be countered if the government takes measures to support the drug industry. Moreover, the developed nations should offer their help to the needy to permanently eliminate this issue and save a lot of families from suffering.
In my opinion, saving human lives should be considered as our number one priority and every possible measure should be taken to do that, but managing the finances is a formidable challenge. How drug companies, nations, and governments respond to this challenge will dramatically affect the future of this world.